Jane J. Zara

Array ( [id] => 7169058 [patent_doc_number] => 20040077570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Antisense modulation of fatty acid synthase expression' [patent_app_type] => new [patent_app_number] => 10/274085 [patent_app_country] => US [patent_app_date] => 2002-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32882 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077570.pdf [firstpage_image] =>[orig_patent_app_number] => 10274085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692575 [patent_doc_number] => 20030040007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Human BMP-7 promoter and method for exploring bone-related substance by using the same' [patent_app_type] => new [patent_app_number] => 10/263788 [patent_app_country] => US [patent_app_date] => 2002-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2712 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040007.pdf [firstpage_image] =>[orig_patent_app_number] => 10263788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787575 [patent_doc_number] => 20030138814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Oligonucleotide conjugates' [patent_app_type] => new [patent_app_number] => 10/255535 [patent_app_country] => US [patent_app_date] => 2002-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13061 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138814.pdf [firstpage_image] =>[orig_patent_app_number] => 10255535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745678 [patent_doc_number] => 20030022861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Therapeutic treatment' [patent_app_type] => new [patent_app_number] => 10/245986 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3873 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022861.pdf [firstpage_image] =>[orig_patent_app_number] => 10245986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6682643 [patent_doc_number] => 20030118507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Methods of using 46828, a human acyl-CoA synthetase' [patent_app_type] => new [patent_app_number] => 10/245537 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 48031 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118507.pdf [firstpage_image] =>[orig_patent_app_number] => 10245537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817863 [patent_doc_number] => 20030068821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Method for expression of small RNA molecules within a cell' [patent_app_type] => new [patent_app_number] => 10/243816 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11924 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068821.pdf [firstpage_image] =>[orig_patent_app_number] => 10243816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674341 [patent_doc_number] => 20030059944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Method for expression of small antiviral RNA molecules within a cell' [patent_app_type] => new [patent_app_number] => 10/243553 [patent_app_country] => US [patent_app_date] => 2002-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13310 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059944.pdf [firstpage_image] =>[orig_patent_app_number] => 10243553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809577 [patent_doc_number] => 20030199516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Methods of treating infection by drug resistant bacteria' [patent_app_type] => new [patent_app_number] => 10/244142 [patent_app_country] => US [patent_app_date] => 2002-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16228 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199516.pdf [firstpage_image] =>[orig_patent_app_number] => 10244142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765713 [patent_doc_number] => 20030100113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Non-viral transfection vector' [patent_app_type] => new [patent_app_number] => 10/225301 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7324 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100113.pdf [firstpage_image] =>[orig_patent_app_number] => 10225301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518799 [patent_doc_number] => 20020192188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft' [patent_app_type] => new [patent_app_number] => 10/215164 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9768 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192188.pdf [firstpage_image] =>[orig_patent_app_number] => 10215164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 540935 [patent_doc_number] => 07169588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism' [patent_app_type] => utility [patent_app_number] => 10/213203 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13750 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169588.pdf [firstpage_image] =>[orig_patent_app_number] => 10213203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7104005 [patent_doc_number] => 20050106731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'siRNA-mediated gene silencing with viral vectors' [patent_app_type] => utility [patent_app_number] => 10/212322 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21177 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106731.pdf [firstpage_image] =>[orig_patent_app_number] => 10212322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7400049 [patent_doc_number] => 20040023382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of PPP3CB expression' [patent_app_type] => new [patent_app_number] => 10/210723 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31249 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023382.pdf [firstpage_image] =>[orig_patent_app_number] => 10210723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395597 [patent_doc_number] => 20040022765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of Ran GTPase activating protein 1 expression' [patent_app_type] => new [patent_app_number] => 10/211859 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30137 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20040022765.pdf [firstpage_image] =>[orig_patent_app_number] => 10211859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7400039 [patent_doc_number] => 20040023380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of G protein-coupled receptor 6 expression' [patent_app_type] => new [patent_app_number] => 10/210479 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30686 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023380.pdf [firstpage_image] =>[orig_patent_app_number] => 10210479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7400025 [patent_doc_number] => 20040023379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antisense modulation of hepatoma-derived growth factor expression' [patent_app_type] => new [patent_app_number] => 10/210429 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30421 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023379.pdf [firstpage_image] =>[orig_patent_app_number] => 10210429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715846 [patent_doc_number] => 20030027194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Modular assembly of nucleic acid-protein fusion multimers' [patent_app_type] => new [patent_app_number] => 10/208967 [patent_app_country] => US [patent_app_date] => 2002-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9987 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027194.pdf [firstpage_image] =>[orig_patent_app_number] => 10208967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6696714 [patent_doc_number] => 20030108908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Hansenula polymorpha mutants and process for the preparation of recombinant proteins using the same' [patent_app_type] => new [patent_app_number] => 10/206619 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13507 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108908.pdf [firstpage_image] =>[orig_patent_app_number] => 10206619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582081 [patent_doc_number] => 07445891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Nucleic acid triggered catalytic drug and probe release' [patent_app_type] => utility [patent_app_number] => 10/201680 [patent_app_country] => US [patent_app_date] => 2002-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14454 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/445/07445891.pdf [firstpage_image] =>[orig_patent_app_number] => 10201680 [rel_patent_id] =>[rel_patent_doc_number] =>)